Yıl: 2023 Cilt: 10 Sayı: 2 Sayfa Aralığı: 228 - 236 Metin Dili: İngilizce DOI: 10.14744/nci.2021.62713 İndeks Tarihi: 03-06-2023

Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients

Öz:
OBJECTIVE: Rheumatic diseases in children are chronic and multisystemic diseases. In this study, it was aimed to evaluate gastrointestinal endoscopic findings in children diagnosed as autoimmune or autoinflammatory rheumatic diseases consulted with pediatric gastroenterology for gastrointestinal complaints. METHODS: The patients followed up by the Pediatric Rheumatology Department and consulted to the Pediatric Gastroenterology Department due to gastrointestinal complaints were included in the study. File records of the patients were analyzed retrospectively. RESULTS: A total of 28 patients were included in the study. Twelve of the patients had autoimmune disease (Juvenile idio- pathic arthritis [JIA], systemic lupus erythematosus, Sjögren’s syndrome, and scleroderma) and the other 16 had autoinflam- matory disease (familial Mediterrnean fever, hyper Immunoglobulin D syndrome, undifferantiated systemic autoinflammatory disease, and systemic JIA). Four of the patients with familial Mediterrnean fever also diagnosed as JIA. The mean age of the patients was 11.7±3.5 years. The main gastrointestinal complaints of patients with both autoimmune and autoinflammatory diseases were abdominal pain and diarrhea. Inflammatory bowel disease was found in 33% of those with autoimmune dis- ease and 56% of those with autoinflammatory disease in patients underwent endoscopic evaluation. M694V mutation was present in 62% of the patients with autoinflammatory disease presented with gastrointestinal complaints. CONCLUSION: Both autoimmune and autoinflammatory rheumatic diseases can cause gastrointestinal complaints and should be referred to a pediatric gastroenterologist for early diagnosis.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Liu E, Perl A. Pathogenesis and treatment of autoimmune rheumatic diseases. Curr Opin Rheumatol 2019;31:307–15.
  • 2. Harapas CR, Steiner A, Davidson S, Masters SL. An update on au- toinflammatory diseases: inflammasomopathies. Curr Rheumatol Rep 2018:20:40.
  • 3. Yıldız M, Haşlak F, Adrovic A, Barut K, Kasapçopur Ö. Autoinflam- matory diseases in childhood. Balkan Med J 2020;37:236–46.
  • 4. Kröner PT, Tolaymat OA, Bowman AW, Abril A, Lacy BE. Gastroin- testinal manifestations of rheumatological diseases. Am J Gastroenterol 2019;114:1441–54.
  • 5. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Golden- berg J, et al; International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390–2.
  • 6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
  • 7. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Li- etman TM, et al; International Sjögren’s Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syn- drome: a consensus and data-driven methodology involving three inter- national patient cohorts. Ann Rheum Dis 2017;76:916.
  • 8. Zulian F, Woo P, Athreya BH, Laxer RM, Medsger TA Jr, Lehman TJ, et al. The Pediatric Rheumatology Society/American College of Rheuma- tology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 2007; 57: 203–12.
  • 9. Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevish I, et al. Classificiation criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 2019;78:1025–32.
  • 10. Yalçinkaya F, Ozen S, Ozçakar ZB, Aktay N, Cakar N, Düzova A, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009;48:395–8.
  • 11. Stolte M, Meining A. The updated Sydney system: classification and grading of gastritis as the basis of diagnosis and treatment. Can J Gas- troenterol 2001;15:591–8.
  • 12. Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Got- trand F, et al. Pediatric gastroesophageal reflux clinical practice guide- lines: joint recommendations of the North American Society for Pedi- atric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2018;66:516–54.
  • 13. Papadopoulou A, Koletzko S, Heuschkel R, Dias JA, Allen KJ, Murch SH, et al. Management guidelines of eosinophilic esophagitis in child- hood. J Pediatr Gastroenterol Nutr 2014;58:107–18.
  • 14. Husby S, Koletzko S, Korponay-Szabo I, Kurppa K, Mearin ML, Ribes-Koninckx C, et al. European Society Paediatric Gastroenterol- ogy, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr 2020;70:141–56.
  • 15. Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, et al. ESPGHAN revised Porto criteria for the diagnosis of inflamma- tory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014;58:795–806.
  • 16. Pichler J, Ong C, Shah N, Sebire N, Kiparrissi F, Borrelli O, et al. Histopathological features of gastrointestinal mucosal biopsies in chil- dren with juvenile idiopathic arthritis. Pediatr Res 2016;79:895–901.
  • 17. Beşer OF, Kasapçopur O, Cokuğraş FC, Kutlu T, Arsoy N, Erkan T. Association of inflammatory bowel disease with familial Mediterranean fever in Turkish children. J Pediatr Gastroenterol Nutr 2013;56:498– 502.
  • 18. Maller J, Fox E, Park KT, Paul SS, Baszis K, Borocco C, et al. Inflamma- tory bowel disease in children with systemic juvenile idiopathic arthri- tis. J Rheumatol 2021;48:567–74.
  • 19. Barthel D, Ganser G, Kuester RM, Onken N, Minden K, Girschick HJ, et al. Inflammatory bowel disease in juvenile idiopathic arthritis pa- tients treated with biologics. J Rheumatol 2015;42:2160–5.
  • 20. Magg T, Shcherbina A, Arslan D, Desai MM, Wall S, Mitsialis V, et al. CARMIL2 deficiency presenting as very early onset inflammatory bowel disease. Inflamm Bowel Dis 2019;25:1788–95.
  • 21. Liang Y, Cucchetti M, Roncagalli R, Yokosuka T, Malzac A, Bertosio E, et al. The lymphoid lineage-specific actin-uncapping protein Rltpr is essential for costimulation via CD28 and the development of regulatory T cells. Nat Immunol 2013;14:858–66.
  • 22. Tian XP, Zhang X. Gastrointestinal involvement in systemic lupus ery- thematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol 2010;16:2971–7.
  • 23. Richer O, Ulinski T, Lemelle I, Ranchin B, Loirat C, Piette JC, et al. Abdominal manifestations in childhood-onset systemic lupus erythe- matosus. Ann Rheum Dis 2007;66:174–8.
  • 24. Menko FH, Kaspers GL, Meijer GA, Claes K, van Hagen JM, Gille JJ. A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer. Fam Cancer 2004;3:123–7.
  • 25. Lecouffe-Desprets M, Groh M, Bour B, Le Jeunne C, Puechal X. Eosinophilic gastrointestinal disorder preceding Sjögren’s syndrome. Joint Bone Spine 2017;84:109–10.
  • 26. Balaban DV, Mihai A, Dima A, Popp A, Jinga M, Jurcut C. Celiac disease and Sjögren’s syndrome: a case report and review of literature. World J Clin Cases 2020;8:4151–61.
  • 27. Bartoloni E, Bistoni O, Alunno A, Cavagna L, Nalotto L, Baldini C, et al. Celiac disease prevalence is increased in primary Sjögren’s syndrome and diffuse systemic sclerosis: lessons from a large multi-center study. J Clin Med 2019;8:540.
  • 28. Sherman Y, Karanicolas R, DiMarco B, Pan N, Adams AB, Barin- stein LV, et al. Unrecognized celiac disease in children presenting for rheumatology evaluation. Pediatrics 2015;136:e68–75.
  • 29. Stevens BE, Torok KS, Li SC, Hershey N, Curran M, Higgins GC, et al. Clinical characteristics and factors associated with disability and im- paired quality of life in children with juvenile systemic sclerosis: results from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis Care Res (Hoboken) 2018;70:1806–13.
  • 30. Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, et al. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset dis- ease. J Rheumatol 2006;33:1004–13.
  • 31. Wang RH. From reflux esophagitis to Barrett’s esophagus and esophageal adenocarcinoma. World J Gastroenterol 2015;21:5210–9.
  • 32. Wipff J, Coriat R, Masciocchi M, Caramaschi P, Derk CT, Hachulla E, et al. Outcomes of Barrett’s oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study. Rheumatology (Oxford) 2011;50:1440–4.
  • 33. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al. Fanilial Mediterranean fever (FMF) in Turkey: results of nationwide multicenter study. Medicine (Baltimore) 2005;84:1–11.
  • 34. Rozenbaum M, Rosner I. Severe outcome of juvenile idiopathic arthri- tis ( JIA) associated with familial Mediterranean fever (FMF). Clin Exp Rheumatol 2004;22:S75–8.
  • 35. Comak E, Dogan CS, Akman S, Koyun M, Gokceoglu AU, Keser I. MEFV gene mutations in Turkish children with juvenile idiopathic arthritis. Eur J Pediatr 2013;172:1061–7.
  • 36. Zhong L, Wang W, Li J, Ma M, Gou L, Wang C, et al. The association of MEFV gene mutations with the disease risk and severity of systemic juvenile idiopathic arthritis. Pediatr Rheumatol 2020;18:38.
  • 37. Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, in- teracts directly with caspase-1 to modulate IL-1 beta production. Proc Natl Acad Sci U S A 2006;103:9982–7.
  • 38. Kuloglu Z, Ozcakar ZB, Kirsaclioglu C, Yuksel S, Kansu A, Girgin N, et al. Is there an association between familial Mediterranean fever and celiac disease? Clin Rheumatol 2008;27:1135–9.
  • 39. Isikay S, Isikay N, Kocamaz H. The prevalence of celiac disease among patients with familial Mediterranean fever. Arq Gastroenterol 2015;52:55–8.
  • 40. Sahin Y, Adrovic A, Barut K, Kutlu T, Cullu-Cokugras F, Sahin S, et al. The frequency of the celiac disease among children with familial Mediterranean fever. Mod Rheumatol 2017;27:1036–9.
  • 41. Moreira A, Torres B, Peruzzo J, Mota A, Eyerich K, Ring J. Skin symp- toms as diagnostic clue for autoinflammatory diseases. An Bras Derma- tol 2017;92:72–80.
  • 42. Jeyaratnam J, Frenkel J. Management of mevalonate kinase deficiency: a pediatric perspective. Front Immunol 2020;11:1150.
  • 43. Martins A, Berrebi D, De Lumley L, Petit B, Pellegrino B, Arion A, et al. Mevalonate kinase deficiency: an early onset inflammatory bowel disease? Pediatric Rheumatology 2015;13 Suppl 1:O56.
APA Altay D, Pac Kisaarslan A, ARSLAN D (2023). Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. , 228 - 236. 10.14744/nci.2021.62713
Chicago Altay Derya,Pac Kisaarslan Aysenur,ARSLAN DURAN Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. (2023): 228 - 236. 10.14744/nci.2021.62713
MLA Altay Derya,Pac Kisaarslan Aysenur,ARSLAN DURAN Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. , 2023, ss.228 - 236. 10.14744/nci.2021.62713
AMA Altay D,Pac Kisaarslan A,ARSLAN D Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. . 2023; 228 - 236. 10.14744/nci.2021.62713
Vancouver Altay D,Pac Kisaarslan A,ARSLAN D Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. . 2023; 228 - 236. 10.14744/nci.2021.62713
IEEE Altay D,Pac Kisaarslan A,ARSLAN D "Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients." , ss.228 - 236, 2023. 10.14744/nci.2021.62713
ISNAD Altay, Derya vd. "Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients". (2023), 228-236. https://doi.org/10.14744/nci.2021.62713
APA Altay D, Pac Kisaarslan A, ARSLAN D (2023). Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. İstanbul Kuzey Klinikleri, 10(2), 228 - 236. 10.14744/nci.2021.62713
Chicago Altay Derya,Pac Kisaarslan Aysenur,ARSLAN DURAN Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. İstanbul Kuzey Klinikleri 10, no.2 (2023): 228 - 236. 10.14744/nci.2021.62713
MLA Altay Derya,Pac Kisaarslan Aysenur,ARSLAN DURAN Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. İstanbul Kuzey Klinikleri, vol.10, no.2, 2023, ss.228 - 236. 10.14744/nci.2021.62713
AMA Altay D,Pac Kisaarslan A,ARSLAN D Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. İstanbul Kuzey Klinikleri. 2023; 10(2): 228 - 236. 10.14744/nci.2021.62713
Vancouver Altay D,Pac Kisaarslan A,ARSLAN D Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients. İstanbul Kuzey Klinikleri. 2023; 10(2): 228 - 236. 10.14744/nci.2021.62713
IEEE Altay D,Pac Kisaarslan A,ARSLAN D "Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients." İstanbul Kuzey Klinikleri, 10, ss.228 - 236, 2023. 10.14744/nci.2021.62713
ISNAD Altay, Derya vd. "Gastrointestinal endoscopic findings of autoimmune and autoinflammatory diseases in pediatric rheumatology patients". İstanbul Kuzey Klinikleri 10/2 (2023), 228-236. https://doi.org/10.14744/nci.2021.62713